Mountain Valley MD Holdings Inc. (“Mountain Valley MD” or the “Company”) (CSE: MVMD) (OTCQB: MVMDF) (FRA: 20MP), a forward-thinking biotechnology company committed to delivering innovative health and wellness solutions, is pleased to announce a significant enhancement to its governance structure with the appointment of David Batchelor to its Board of Directors. This leadership update reflects the Company’s strategic focus on disciplined growth, commercialization of its technologies, and building long-term shareholder value.
David Batchelor joins Mountain Valley MD with an extensive and diverse background in organizational strategy, enterprise transformation, and board-level advisory work. With more than 25 years of experience guiding executive teams and boards across multiple industries, Mr. Batchelor has developed a strong reputation for driving operational excellence, strategic clarity, and measurable business outcomes.
A Proven Leader in Organizational Strategy and Transformation
Mr. Batchelor’s career has spanned a wide array of sectors including finance, healthcare, technology, consumer goods, and advanced manufacturing. His client roster reads like a who’s who of global industry leaders, having partnered with prominent companies such as Cisco Systems, Coca-Cola, IBM, Merck, Bayer, and Johnson & Johnson. His work has focused on helping organizations navigate complex challenges, optimize internal processes, and execute strategies that enhance performance and unlock enterprise value.
Recognized for his ability to blend systems thinking with pragmatic execution, Mr. Batchelor specializes in aligning leadership, governance, and financial strategies to help companies realize their full potential. His insights into capital allocation, organizational alignment, and performance science have delivered demonstrable improvements in accountability, profitability, and strategic focus across enterprises both large and small.
“We are very excited to welcome David Batchelor to our Board of Directors at this pivotal juncture in Mountain Valley MD’s growth journey,” said Dennis Hancock, President and CEO of MVMD. “David brings a deep well of experience in business transformation, governance, and financial discipline. His appointment strengthens our leadership team and supports our priorities around product commercialization, operational scalability, and responsible capital deployment.”
A Scholar-Practitioner with a People-Centric Approach
In addition to his consulting and advisory experience, Mr. Batchelor is also an accomplished academic and educator. He holds a Master’s degree in Distributed Learning with a concentration in Organizational Leadership, alongside undergraduate studies in Management Science. He has also completed coursework through the Certified Management Accountant (CMA) program, which further underscores his financial expertise.
Throughout his career, Mr. Batchelor has demonstrated a commitment to sharing his knowledge and developing future leaders. He has held faculty and program leadership positions at the Schulich Executive Education Centre (York University) and Royal Roads University, where he has taught on topics such as strategic leadership, change management, and governance. He is also a published author in the field of performance improvement and leadership development.
His practical, human-centered approach to leadership and transformation is especially relevant in today’s business climate, where organizations must adapt rapidly to evolving market dynamics while maintaining a strong internal culture and operational integrity.
Strategic Board Changes Reflect Evolving Business Needs
As part of its ongoing efforts to align its board composition with strategic business objectives, Mountain Valley MD also announced the resignations of Kevin Puloski and Nancy Richardson from the Board of Directors. Both individuals have served with distinction, contributing to the Company’s evolution during a critical period of growth and early-stage innovation.
Mr. Hancock expressed his appreciation for their service, stating: “On behalf of the entire team at Mountain Valley MD, I want to thank Kevin and Nancy for their dedication and the valuable contributions they have made to the Company. As we transition into the next phase of our development—focused on commercialization and capital markets execution—we are reshaping our governance structure to better reflect these priorities. We wish Kevin and Nancy continued success in their future endeavors.”
The addition of Mr. Batchelor signals MVMD’s intent to elevate board oversight capabilities, particularly in areas such as financial rigor, strategic alignment, and performance execution. His appointment aligns with a broader initiative to ensure that the Company is well-positioned to meet the demands of global markets, regulatory environments, and increasingly sophisticated investor expectations.
A Future-Focused Vision for Growth and Commercialization
Mountain Valley MD has emerged as a company to watch in the health and wellness sector, with a growing portfolio of proprietary technologies and delivery systems. The Company’s innovations span vaccine delivery, nutraceuticals, and pharmaceutical formulations, with several promising platforms currently undergoing development and commercialization.
The appointment of a board member with Mr. Batchelor’s caliber and experience reflects MVMD’s intention to accelerate its go-to-market strategy and strengthen its organizational infrastructure. His expertise will be instrumental in advising the executive team as they pursue partnerships, enter new markets, and execute against a carefully designed roadmap for value creation.
“David’s proven track record of working alongside global industry leaders to drive sustained business performance makes him an ideal addition to our board,” added Mr. Hancock. “We look forward to leveraging his insights as we navigate the next phase of growth and continue to build a company that is positioned for long-term impact and shareholder value.”
About Mountain Valley MD Holdings Inc.
Mountain Valley MD Holdings Inc. is a Canadian-based company focused on the life sciences sector, with a mission to deliver innovative health and wellness products using advanced formulation and delivery technologies. The Company’s patented Quicksome™ delivery system and other proprietary solutions are designed to optimize bioavailability, speed of absorption, and patient outcomes. MVMD is actively engaged in developing applications across multiple verticals, including human health, animal health, and global vaccine delivery.
Through ongoing research, strategic partnerships, and a commitment to scientific excellence, Mountain Valley MD is advancing a new paradigm in health product delivery—one that is more efficient, effective, and accessible.
